Sort   by:  
 Page size 
UnknownMobilities of a drop and an encapsulated squirmer.
Not available
S-EPMC8860840 | biostudies-literature
UnknownCorticosteroid-resistant immune-related adverse events: a systematic review.
Not available
S-EPMC10806650 | biostudies-literature
UnknownA highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression.
Not available
S-EPMC11027827 | biostudies-literature
UnknownRNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types.
Not available
S-EPMC6367568 | biostudies-literature
UnknownMetastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cells.
Not available
S-EPMC11028782 | biostudies-literature
UnknownTumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy.
Not available
S-EPMC7537339 | biostudies-literature
UnknownPlinabulin, a Distinct Microtubule-Targeting Chemotherapy, Promotes M1-Like Macrophage Polarization and Anti-tumor Immunity.
Not available
S-EPMC7966525 | biostudies-literature
UnknownTargeting Insulin-Like Growth Factor-I and Extracellular Matrix Interactions in Melanoma Progression.
Not available
S-EPMC5766529 | biostudies-literature
UnknownPre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities.
Not available
S-EPMC10278511 | biostudies-literature
UnknownA novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer.
Not available
S-EPMC6341578 | biostudies-literature
Sort   by:  
 Page size